These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 21618978

  • 1. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z, Salassa L, Habtemariam A, Pizarro AM, Clarkson GJ, Sadler PJ.
    Inorg Chem; 2011 Jun 20; 50(12):5777-83. PubMed ID: 21618978
    [Abstract] [Full Text] [Related]

  • 2. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T, Habtemariam A, Stepankova J, Heringova P, Kasparkova J, Deeth RJ, Johnstone RD, Prescimone A, Parkin A, Parsons S, Brabec V, Sadler PJ.
    Inorg Chem; 2008 Dec 15; 47(24):11470-86. PubMed ID: 19007206
    [Abstract] [Full Text] [Related]

  • 3. Organometallic half-sandwich iridium anticancer complexes.
    Liu Z, Habtemariam A, Pizarro AM, Fletcher SA, Kisova A, Vrana O, Salassa L, Bruijnincx PC, Clarkson GJ, Brabec V, Sadler PJ.
    J Med Chem; 2011 Apr 28; 54(8):3011-26. PubMed ID: 21443199
    [Abstract] [Full Text] [Related]

  • 4. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH, Peacock AF, Johnstone RD, Parsons S, Sadler PJ.
    Inorg Chem; 2009 Feb 16; 48(4):1753-62. PubMed ID: 19146436
    [Abstract] [Full Text] [Related]

  • 5. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF, Habtemariam A, Moggach SA, Prescimone A, Parsons S, Sadler PJ.
    Inorg Chem; 2007 May 14; 46(10):4049-59. PubMed ID: 17441712
    [Abstract] [Full Text] [Related]

  • 6. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF, Parsons S, Sadler PJ.
    J Am Chem Soc; 2007 Mar 21; 129(11):3348-57. PubMed ID: 17319668
    [Abstract] [Full Text] [Related]

  • 7. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC, van der Geer EP, Caspers SE, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    Inorg Chem; 2004 Aug 09; 43(16):4935-43. PubMed ID: 15285670
    [Abstract] [Full Text] [Related]

  • 8. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK, Law WH, Liu HW, Lo KK.
    Inorg Chem; 2011 Sep 05; 50(17):8570-9. PubMed ID: 21834537
    [Abstract] [Full Text] [Related]

  • 9. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G, Mijatović S, Ranđelović I, Bulatović M, Miljković D, Maksimović-Ivanić D, Korb M, Lang H, Steinborn D, Kaluđerović GN.
    Eur J Med Chem; 2013 Nov 05; 69():216-22. PubMed ID: 24042044
    [Abstract] [Full Text] [Related]

  • 10. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H, Parkinson JA, Parsons S, Coxall RA, Gould RO, Sadler PJ.
    J Am Chem Soc; 2002 Mar 27; 124(12):3064-82. PubMed ID: 11902898
    [Abstract] [Full Text] [Related]

  • 11. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S, Shakthipriya D, Suresh E, Periasamy VS, Akbarsha MA, Palaniandavar M.
    Inorg Chem; 2011 Jul 18; 50(14):6458-71. PubMed ID: 21671566
    [Abstract] [Full Text] [Related]

  • 12. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF, Habtemariam A, Fernández R, Walland V, Fabbiani FP, Parsons S, Aird RE, Jodrell DI, Sadler PJ.
    J Am Chem Soc; 2006 Feb 08; 128(5):1739-48. PubMed ID: 16448150
    [Abstract] [Full Text] [Related]

  • 13. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
    Pérez-Quintanilla D, Gómez-Ruiz S, Zizak Z, Sierra I, Prashar S, del Hierro I, Fajardo M, Juranić ZD, Kaluderović GN.
    Chemistry; 2009 Feb 08; 15(22):5588-97. PubMed ID: 19370742
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF, Göschl S, Jakupec MA, Roller A, Keppler BK, Arion VB.
    Inorg Chem; 2010 Dec 06; 49(23):11084-95. PubMed ID: 20979395
    [Abstract] [Full Text] [Related]

  • 15. Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.
    Millett AJ, Habtemariam A, Romero-Canelón I, Clarkson GJ, Sadler PJ.
    Organometallics; 2015 Jun 08; 34(11):2683-2694. PubMed ID: 26146437
    [Abstract] [Full Text] [Related]

  • 16. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T, Habtemariam A, Deeth RJ, Fabbiani FP, Parsons S, Sadler PJ.
    Inorg Chem; 2009 Oct 05; 48(19):9444-53. PubMed ID: 19780621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z.
    Inorg Chem; 2018 Feb 19; 57(4):1705-1716. PubMed ID: 29400963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.